Browsing Tag
NSE: SURAKSHA
1 post
Suraksha Diagnostic Q1 FY26 results: How revenue growth, genomics expansion, and acquisitions are shaping investor outlook
Suraksha Diagnostic Q1 FY26 revenue up 18.83%, PAT up 19.67%. See how genomics, acquisitions, and expansion are shaping its growth outlook.